Mishustin said during his speech at the plenary session of the “Union of New Technologies: Building the Industry of the Future” conference in the Belarusian capital, Minsk: “There are other advanced drugs in their final stages of development for the treatment of leukemia and anti-tumor medications.” Dr. Konstantin Belosludtsev, a Doctor of Biological Sciences and Vice President of Mari University for Innovative Activities, stated, “Research results have shown that the new substance effectively inhibits the growth of various malignant cells, including liver cancer, adenocarcinoma of the lung, colorectal cancer, and leukemia, demonstrating effectiveness even at low concentrations, which makes it particularly promising for drug development.”
